Medical research

Regenerative eyedrops tap blood for tears – Mayo Clinic News Network

Gregory Williams turned to regenerative medicine for healing after a one-two punch to his health. The 63-year-old Florida man survived leukemia only to develop ocular graft-versus-host disease, a potentially blinding complication of the bone marrow transplant that put his cancer in remission.

Ocular graft-versus-host disease is a chronic debilitating condition with no cure that causes severe dry eyes. The Regenerative Medicine Therapeutic Suites in Florida, recognizing an unmet patient need, began producing and offering a treatment known as autologous serum eyedrops to regenerate moisture. These eyedrops are made from a patient’s own blood.

The Mayo Clinic Center for Regenerative Medicine has been a driver of advancing regenerative care, together with the Regenerative Medicine Therapeutic Suites, as a leader in outpatient regenerative procedures.

“Autologous serum eyedrops are considered a compound medication that is manufactured from serum extracted from a patient’s own blood. The eyedrops utilize cells and growth factors to modify the ocular surface and restore the body’s ability to produce natural tears,” says Jennifer Arthurs, a nurse practitioner in the Regenerative Medicine Therapeutic Suites.

Read the rest of the article on the Center for Regenerative Medicine blog.


Other Mayo Clinic medical research websites:

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.